RESUMEN
Objetivo: Evaluar los valores individuales del U-score como factores predictores de la cirugía uretral compleja.Métodos: Estudio transversal que incluye a los pacientes que recibieron una uretroplastia anterior entre 2011 y 2019. Se midieron las variables del U-score (etiología [1-2 puntos], número de estenosis [1-2 puntos], localización anatómica (1-2 puntos) y longitud [1-3 puntos]) de manera individual y total. La complejidad quirúrgica se definió como baja (anastomosis, injerto de mucosa oral y uretroplastia anterior ampliada) y alta (injerto doble de mucosa oral, colgajo y combinación de injerto y colgajo). Los componentes del U-score se incluyeron como predictores de cirugía compleja y como variables principales con estimaciones y comparaciones de los valores de probabilidad individuales. Se establecieron grupos según la probabilidad de riesgo de cirugía compleja.Resultados: Se incluyeron 654 pacientes. La edad media fue de 57,2 años. Se realizó cirugía de baja complejidad en 464 pacientes (259 anastomosis, 144 injertos, 61 uretroplastia anterior aumentada) y de alta complejidad en 190 (53 injerto doble de mucosa oral, 27 colgajo, 110 combinación injerto/colgajo). En el análisis multivariante, la longitud, el número de estenosis y la localización fueron predictores de complejidad. La introducción del U-score como única variable en el modelo univariante predijo una OR de 8,52 (IC 95%: 6,1-11). Los grupos del U-score simplificado obtenidos por probabilidad de complejidad fueron: riesgo bajo (4-5 puntos), riesgo intermedio (6 puntos) y riesgo alto de complejidad (7-9 puntos) La predicción del riesgo de probabilidad de cirugía compleja (IC 95%) para el grupo de riesgo bajo, medio y alto fue de 1,6 (0-2,9), 19,1 (13,8-25,9) y 77,9 (61,6-88,7), respectivamente.Conclusiones: El U-score puede utilizarse como una herramienta predictiva de la cirugía uretral compleja. Presentamos la herramienta de riesgo U-score simplificado para evaluar
Objective: To assess U-score individual values as urethral complex surgery predictors.Methods: Cross-sectional study including patients who received anterior urethroplasty from 2011 to 2019. U-score (etiology (1-2 points), number of strictures (1-2 points), anatomic location (1-2 points) and length (1-3 points)) was measured individually and globally. Surgical complexity was defined as low (anastomotic, buccal mucosal graft, and augmented anterior urethroplasty), and high complexity (double buccal mucosal graft, flap, and graft/flap combination). U-score components were included as complex surgery predictor and as main variable with individual probability values estimations and comparisons. Risk complex surgery probability groups were established.Results: 654 patients were included. Mean age was 57.2 years. Low complexity surgery was performed in 464 patients (259 anastomotic, 144 graft, 61 augmented anterior urethroplasty) and high complexity was done in 190 (53 double buccal mucosa graft, 27 flap, 110 graft/flap comb.). In multivariate analysis length, number of strictures and location were predictors of complexity. Introducing U-Score as only variable in univariate model predicted an OR 8.52 (95%CI 6.1-11). Simplified U-score grouping set obtained by complex probability was: low risk (4-5 points), medium risk (6 points) and high risk of complexity (7-9 points) Predicted risk of complex surgery probability (95%CI) for low, median and high risk group were 1.6 (0-2.9), 19.1 (13.8-25.9) and 77.9 (61.6-88.7), respectively.Conclusions: U-score can be used as a tool to predict complex urethral surgery. We present a simplified U-score risk tool to assess individual complex anterior urethroplasty probability (AU)
Asunto(s)
Humanos , Masculino , Adulto , Persona de Mediana Edad , Anciano , Estrechez Uretral/cirugía , Procedimientos Quirúrgicos Urológicos Masculinos , Valor Predictivo de las Pruebas , Resultado del Tratamiento , Estudios TransversalesRESUMEN
OBJECTIVE: To assess U-score individual values as urethral complex surgery predictors. METHODS: Cross-sectional study including patients who received anterior urethroplasty from 2011 to 2019. U-score (etiology (1-2 points), number of strictures (1-2 points), anatomic location (1-2 points) and length (1-3 points)) was measured individually and globally. Surgical complexity was defined as low (anastomotic, buccal mucosal graft, and augmented anterior urethroplasty), and high complexity (double buccal mucosal graft, flap, and graft/flap combination). U-score components were included as complex surgery predictor and as main variable with individual probability values estimations and comparisons. Risk complex surgery probability groups were established. RESULTS: 654 patients were included. Mean age was 57.2 years. Low complexity surgery was performed in 464 patients (259 anastomotic, 144 graft, 61 augmented anterior urethroplasty) and high complexity was done in 190 (53 double buccal mucosa graft, 27 flap, 110 graft/flap comb.). In multivariate analysis length, number of strictures and location were predictors of complexity. Introducing U-Score as only variable in univariate model predicted an OR 8.52 (95%CI 6.1-11). Simplified U-score grouping set obtained by complex probability was: low risk (4-5 points), medium risk (6 points) and high risk of complexity (7-9 points) Predicted risk of complex surgery probability (95%CI) for low, median and high risk group were 1.6 (0-2.9), 19.1 (13.8-25.9) and 77.9 (61.6-88.7), respectively. CONCLUSIONS: U-score can be used as a tool to predict complex urethral surgery. We present a simplified U-score risk tool to assess individual complex anterior urethroplasty probability.
Asunto(s)
Estrechez Uretral , Constricción Patológica , Estudios Transversales , Humanos , Masculino , Persona de Mediana Edad , Uretra/cirugía , Estrechez Uretral/cirugía , Procedimientos Quirúrgicos Urológicos MasculinosRESUMEN
Objetivo: Analizar los resultados y las complicaciones posturetroplastia estratificando a los pacientes por edades. Como objetivo secundario, analizamos el impacto de la complejidad de la cirugía en cada grupo etario.Material y métodosSe trata de un estudio de cohortes, retrospectivo, donde se incluyó a todos los pacientes masculinos a quienes se les practicó uretroplastia entre enero de 2011 y diciembre de 2018. La información se obtuvo de la historia clínica electrónica. Los pacientes se agruparon en menores de 60 años, de 60 a 79 años y mayores de 80 años. Se evaluaron diferentes variables como antecedentes, comorbilidades, cirugías previas, complejidad de la cirugía. Se determinó la supervivencia libre de reestenosis y las complicaciones presentadas en cada grupo, según la clasificación de Clavien Dindo. Se utilizó el programa SPSS® para el análisis estadístico.ResultadosSe incluyeron un total de 783 pacientes. El seguimiento promedio fue de 19 meses. La sobrevida estimada a dos años libre de reestenosis en la población menor a 60, de 60 a 79 y mayor de 80 años fue de 87, 87 y 93,9% (IC 95%), respectivamente. En el análisis univariado, el grupo etario no fue una variable predictora de reestenosis. La realización de cirugía compleja es el único factor predictor de recidiva, aumentando el riesgo en un 60% (HR 1,64 IC 95% 1,05-2,56 p = 0,029). Se presentó una tasa general de complicaciones del 30,8%, siendo el 62% Clavien menor a dos. No encontramos asociación entre la frecuencia de las mismas y la edad. (AU)
Objective: To analyze the results and complications after urethroplasty based on patient age groups. As secondary objective, we analyzed the impact of operative complexity on each age group.Material and methodsThis is a retrospective cohort study that include male patients who underwent urethroplasty between January 2011 and December 2018. Data was obtained from the patients electronic health records. Patients were grouped as follows: < 60 years, 60-79 years and > 80 years. Variables evaluated were history, comorbidities, previous surgeries and operative complexity. Restenosis-free survival and complications presented in each group were determined according to the Clavien-Dindo classification system. The SPSS® program was used for statistical analysis.ResultsA total of 783 patients were included, and the mean follow-up was 19 months. The estimated 2-year restenosis-free survival in the population under 60, 60-79 and over 80 years was 87, 87 and 93.9% (IC 95%), respectively. Univariate analysis showed that the age group was not a predictor of restenosis. Complex surgery is the only predictor of recurrence, increasing the risk by 60% (HR 1.64, 95% CI 1.05-2.56, p = 0.029). There was an overall complication rate of 30.8%, and 62% of these were Clavien ≤ II. We found no association between the frequency of complications and age. (AU)
Asunto(s)
Humanos , Estrechez Uretral , Registros Médicos , Pacientes , ComorbilidadRESUMEN
OBJECTIVE: To analyze the results and complications after urethroplasty based on patient age groups. As secondary objective, we analyzed the impact of operative complexity on each age group. MATERIAL AND METHODS: This is a retrospective cohort study that include male patients who underwent urethroplasty between January 2011 and December 2018. Data was obtained from the patients' electronic health records. Patients were grouped as follows: <60 years, 60-79 years and >80 years. Variables evaluated were history, comorbidities, previous surgeries and operative complexity. Restenosis-free survival and complications presented in each group were determined according to the Clavien-Dindo classification system. The SPSS® program was used for statistical analysis. RESULTS: A total of 783 patients were included, and the mean follow-up was 19 months. The estimated 2-year restenosis-free survival in the population under 60, 60-79 and over 80 years was 87, 87 and 93.9% (IC 95%), respectively. Univariate analysis showed that the age group was not a predictor of restenosis. Complex surgery is the only predictor of recurrence, increasing the risk by 60% (HR 1.64, 95% CI 1.05-2.56, pâ¯=â¯0.029). There was an overall complication rate of 30.8%, and 62% of these were Clavienâ¯≤â¯II. We found no association between the frequency of complications and age. CONCLUSIONS: Urethroplasty is safe and effective regardless of age group. There are no statistically significant differences in outcomes and complications shown by the age group comparison. There were no significant differences when analyzing the impact of complex surgeries among the different age groups. The data indicate that age alone should not be taken as an absolute exclusion criterion for patients needing urethral reconstruction.
Asunto(s)
Procedimientos de Cirugía Plástica , Estrechez Uretral , Humanos , Masculino , Estudios Retrospectivos , Uretra/cirugía , Estrechez Uretral/cirugía , Procedimientos Quirúrgicos Urológicos MasculinosRESUMEN
OBJECTIVE: To analyze the results and complications after urethroplasty based on patient age groups. As secondary objective, we analyzed the impact of operative complexity on each age group. MATERIAL AND METHODS: This is a retrospective cohort study that include male patients who underwent urethroplasty between January 2011 and December 2018. Data was obtained from the patients' electronic health records. Patients were grouped as follows: < 60 years, 60-79 years and > 80 years. Variables evaluated were history, comorbidities, previous surgeries and operative complexity. Restenosis-free survival and complications presented in each group were determined according to the Clavien-Dindo classification system. The SPSS® program was used for statistical analysis. RESULTS: A total of 783 patients were included, and the mean follow-up was 19 months. The estimated 2-year restenosis-free survival in the population under 60, 60-79 and over 80 years was 87, 87 and 93.9% (IC 95%), respectively. Univariate analysis showed that the age group was not a predictor of restenosis. Complex surgery is the only predictor of recurrence, increasing the risk by 60% (HR 1.64, 95% CI 1.05-2.56, p = 0.029). There was an overall complication rate of 30.8%, and 62% of these were Clavien ≤ II. We found no association between the frequency of complications and age. CONCLUSIONS: Urethroplasty is safe and effective regardless of age group. There are no statistically significant differences in outcomes and complications shown by the age group comparison. There were no significant differences when analyzing the impact of complex surgeries among the different age groups. The data indicate that age alone should not be taken as an absolute exclusion criterion for patients needing urethral reconstruction.
Asunto(s)
Infecciones por Coronavirus/epidemiología , Transmisión Vertical de Enfermedad Infecciosa/estadística & datos numéricos , Neumonía Viral/epidemiología , Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/virología , Adolescente , Adulto , Betacoronavirus/aislamiento & purificación , COVID-19 , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/diagnóstico , Femenino , Hospitales Universitarios , Humanos , Recién Nacido , Pandemias , Neumonía Viral/complicaciones , Neumonía Viral/diagnóstico , Embarazo , Complicaciones Infecciosas del Embarazo/diagnóstico , Resultado del Embarazo , Estudios Retrospectivos , SARS-CoV-2 , Suiza/epidemiología , Adulto JovenRESUMEN
OBJECTIVE: To determine the prevalence of postoperative urinary extravasation (POUE) following anterior urethroplasty, to analyze factors associated with its occurrence, and to study the impact of POUE on surgical success. MATERIALS AND METHODS: Retrospective cohort study including all male patients who have undergone a urethroplasty at our center between 2011 and 2018. Subjects with posterior location stricture, those who did not undergo routine radiographic follow-up, or patients with inadequate follow-up were excluded. Urinary extravasation was defined as presence of evident contrast extravasation on the postoperative voiding cystourethrogram (VCUG). Impact was determined as "need-for-reoperation". Uni- and multivariate analysis were performed to determine clinical and demographic variables associated with occurrence of extravasation and postoperative stricture. RESULTS: A total of 783 men underwent a urethroplasty and 630 fulfilled inclusion criteria. Urinary extravasation prevalence was 12.2%, and there was a "need-for-reoperation" in 1.1% of cases. On uni- and multivariate analysis, greatest stricture length (HR: 1.07 (1-1.2), p = 0.05) and penile urethral location (HR: 2.29 (1.1-4.6), p = 0.021) showed to be POUE predictors. POUE did not show to be a risk factor for postoperative stricture (HR: 1.57, 95% CI (0.8-3), p = 0.173). However, reoperation group showed to be a risk factor (HR: 6.6, 95% CI 1.4-31, p = 0.019). CONCLUSIONS: Prevalence of POUE was 12.2%. Stricture length and penile urethral strictures were POUE predictors. POUE occurrence with successful conservative management did not appear to have impact on urethroplasty outcomes as it did not predict re-stricture. POUE was reoperation cause in 1.1% of total cases.
Asunto(s)
Extravasación de Materiales Terapéuticos y Diagnósticos/epidemiología , Complicaciones Posoperatorias/epidemiología , Uretra/cirugía , Estrechez Uretral/cirugía , Orina , Estudios de Cohortes , Humanos , América Latina/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Resultado del Tratamiento , Procedimientos Quirúrgicos Urológicos Masculinos/métodosRESUMEN
BACKGROUND: In liver transplant recipients with hepatitis C virus recurrence, there is concern about renal safety of sofosbuvir-based regimens. Changes in serum creatinine or in the estimated glomerular filtration rate (eGFR) under treatment are used to look for possible renal toxicity. However, serum creatinine and eGFR are highly variable. AIM: To analyse renal function trajectory with numerous assays of serum creatinine over a long period of time. METHODS: In a multicentre cohort of 139 patients, the eGFR was obtained from serum creatinine using the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation. Slopes of eGFR were defined as a change in eGFR during a period divided by time. Pre-treatment, on-treatment and post-treatment periods were 9 months, 3-9 months and 4.5 months. Interactions between eGFR slopes and the pre-treatment eGFR, use of ribavirin or mycophenolate mofetil, and stage of fibrosis were addressed. On-treatment eGFR slopes were separated in tertiles. Pre- and post-treatment eGFR slopes were compared globally and according to tertiles. RESULTS: The post-treatment eGFR slope was significantly better than pre-treatment eGFR slope (+0.18 (IQR -0.76 to +1.32) vs -0.11 (IQR -1.01 to +0.73) mL/min/1.73 m2 /month, P = 0.03) independently of the pre-treatment eGFR (P = 0.99), ribavirin administration (P = 0.26), mycophenolate mofetil administration (P = 0.51) and stage of fibrosis (F3 and F4 vs lower stages, P = 0.18; F4 vs lower stages, P = 0.08; F4 Child-Pugh B and C vs lower stages, P = 0.38). Tertiles of on-treatment eGFR slopes were -1.71 (IQR -2.54 to -1.48), -0.78 (IQR -1.03 to -0.36) and +0.75 (IQR +0.28 to +1.47) mL/min/1.73 m2 /month. Pre- and post-treatment eGFR slopes were not significantly different according to tertiles (respectively, P = 0.34, 0.08, 0.73). CONCLUSION: The eGFR varies during treatment and gives a confusing picture of the renal safety of sofosbuvir-based regimens. In contrast, longitudinal assessment of the eGFR shows a rising trajectory over longer time, meaning that these therapies are safe for the kidneys in our cohort of liver transplant recipients.
Asunto(s)
Hepatitis C/tratamiento farmacológico , Riñón/patología , Trasplante de Hígado/métodos , Sofosbuvir/administración & dosificación , Anciano , Estudios de Cohortes , Creatinina/sangre , Femenino , Tasa de Filtración Glomerular , Hepacivirus/aislamiento & purificación , Humanos , Estudios Longitudinales , Persona de Mediana Edad , Estudios Prospectivos , Recurrencia , Insuficiencia Renal Crónica/epidemiología , Ribavirina/administración & dosificación , Sofosbuvir/efectos adversosRESUMEN
Introducción y objetivo: Evaluar las complicaciones, morbilidad y resultados oncológicos de la exenteración pelviana como tratamiento para los tumores ginecológicos. Materiales y métodos: Entre enero de 2008 y diciembre de 2015, 35 pacientes fueron tratadas mediante exenteración pelviana debido a recurrencia de cáncer de origen ginecológico. Se evaluaron resultados quirúrgicos, complicaciones postoperatorias tempranas y tardías, recurrencia y sobrevida. Resultados: La edad media de las pacientes fue de 53,8 años. Se realizó exenteración anterior en 20 pacientes, mientras que en 15 se realizó exenteración total. En 24 pacientes se realizó derivación urinaria de tipo Bricker, neovejiga ileal en 8 y ureterostomía cutánea en 3. Las complicaciones postoperatorias se dividieron en 2 grupos: tempranas (<30 días) y tardías (>30 días). Un total de 25 pacientes (71,4%) tuvieron una o más complicaciones tempranas; 16 (45,7%) tuvieron fiebre debido a infección urinaria, pielonefritis o colección intraabdominal; 2 (5,7%) evolucionaron con fístula vesicovaginal; 4 (11,4%) con fístula recto vaginal; 3 (8,5%) con insuficiencia renal aguda y uno (2,85%) con uronefrosis. Con respecto a las complicaciones tardías, 8 pacientes (22,8%) tuvieron fiebre. Seis (17%) se presentaron con uronefrosis y 5 (14,2%) con estenosis uretero-pouch. Cinco pacientes (14,2%) tuvieron insuficiencia renal aguda, 3 (8,6%) fístula recto vaginal y una (2,85%) fístula urinaria. El tiempo de seguimiento medio fue de 20,3 meses (rango 2-60). En total, 22 pacientes (62,8%) permanecieron libres de enfermedad. Otras 13 pacientes (37%) recayeron y 4 pacientes (11,4%) murieron luego de la exenteración pelviana debido a la enfermedad de base. No hubo muertes relacionadas a la cirugía. Conclusión: La exenteración pelviana tiene una alta tasa de complicaciones, pero puede ser la última oportunidad curativa en pacientes con tumores ginecológicos. Este procedimiento debería llevarse a cabo por equipos multidisciplinarios, con experiencia, en centros médicos de alta complejidad
Introduction and objective: To evaluate complications, morbidity and oncologic outcomes of pelvic exenteration as treatment for gynecologic malignancies. Materials and methods: Between 2008 and 2015, a total of 35 patients underwent pelvic exenteration, due to recurrence of gynecological cancer. Surgical outcomes, early and late postoperative complications, and recurrence/survival outcomes were assessed. Results: Mean patient age was 53.8 years. Anterior exenteration was done in 20 patients, while 15 were total exenterations. Ileal conduit was done in 24 patients, while 8 received a neobladder and 3 a cutaneous ureterostomy. Postoperative complications were divided in 2 groups, early (< 30 days) and late complications (> 30 days). A total of 25 patients (71.4%) had one or more early complications; 16 (45.7%) had fever due to a urinary tract infection, pyelonephritis or intra-abdominal collection; 2 (5.7%) developed a vesicovaginal fistula; 4 (11.4%) a rectovaginal fistula; 3 (8.5%) acute kidney failure and one (2.85%) uronephrosis. Regarding to late complications, 8 patients (22.8%) had fever. Six (17%) presented with uronephrosis, and 5 (14.2%) with ureteral-pouch stricture. Five patients (14.2%) had acute renal insufficiency, 3 (8,6%) rectovaginal fistula and one (2.85%) urinary fistula. Mean follow up time was 20.3 month (2-60). A total of 22 patients (62.8%) were free of disease. Another 13 (37.1%) patients relapsed. Only 4 (11.4%) patients died after pelvic exenteration due to underlying disease. Conclusion: Pelvic exenteration has a high rate of complications and morbidity, but can be the last curative opportunity in patients with recurrent or persistent gynecologic malignancies. This procedure should be performed by multidisciplinary, experienced teams in a tertiary medical center
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Exenteración Pélvica/métodos , Complicaciones Posoperatorias/cirugía , Neoplasias de los Genitales Femeninos/complicaciones , Neoplasias de los Genitales Femeninos/cirugía , Recurrencia , Ureterostomía/métodos , Derivación Urinaria/métodos , Estudios RetrospectivosRESUMEN
INTRODUCTION AND OBJECTIVE: To evaluate complications, morbidity and oncologic outcomes of pelvic exenteration as treatment for gynecologic malignancies. MATERIALS AND METHODS: Between 2008 and 2015, a total of 35 patients underwent pelvic exenteration, due to recurrence of gynecological cancer. Surgical outcomes, early and late postoperative complications, and recurrence/survival outcomes were assessed. RESULTS: Mean patient age was 53.8 years. Anterior exenteration was done in 20 patients, while 15 were total exenterations. Ileal conduit was done in 24 patients, while 8 received a neobladder and 3 a cutaneous ureterostomy. Postoperative complications were divided in 2groups, early (<30 days) and late complications (>30 days). A total of 25 patients (71.4%) had one or more early complications; 16 (45.7%) had fever due to a urinary tract infection, pyelonephritis or intra-abdominal collection; 2 (5.7%) developed a vesicovaginal fistula; 4 (11.4%) a rectovaginal fistula; 3 (8.5%) acute kidney failure and one (2.85%) uronephrosis. Regarding to late complications, 8patients (22.8%) had fever. Six (17%) presented with uronephrosis, and 5 (14.2%) with ureteral-pouch stricture. Five patients (14.2%) had acute renal insufficiency, 3 (8,6%) rectovaginal fistula and one (2.85%) urinary fistula. Mean follow up time was 20.3 month (2-60). A total of 22patients (62.8%) were free of disease. Another 13 (37.1%) patients relapsed. Only 4 (11.4%) patients died after pelvic exenteration due to underlying disease. CONCLUSION: Pelvic exenteration has a high rate of complications and morbidity, but can be the last curative opportunity in patients with recurrent or persistent gynecologic malignancies. This procedure should be performed by multidisciplinary, experienced teams in a tertiary medical center.
Asunto(s)
Neoplasias de los Genitales Femeninos/cirugía , Recurrencia Local de Neoplasia/cirugía , Exenteración Pélvica , Complicaciones Posoperatorias/epidemiología , Adulto , Anciano , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Exenteración Pélvica/efectos adversos , Exenteración Pélvica/estadística & datos numéricos , Complicaciones Posoperatorias/etiología , Utilización de Procedimientos y Técnicas , Terapia Recuperativa , Resultado del Tratamiento , Derivación Urinaria/estadística & datos numéricosRESUMEN
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, which is mainly due to its high risk of metastatic dissemination. One critical point of this process is the ability of cancer cells to detach from the primary tumor and migrate through the extracellular matrix; however, the underlying molecular mechanisms are not yet fully understood. In the present study, we identified the small GTPase RhoB as a key regulator of bronchial cell morphology in a three-dimensional (3D) matrix. RhoB loss, which is frequently observed during lung cancer progression, induced an epithelial-mesenchymal transition (EMT) characterized by an increased proportion of invasive elongated cells in 3D. The process was mediated by Slug induction and E-cadherin repression. In addition, downregulation of RhoB induced Akt1 activation, which in turn activated Rac1 through the guanine-exchange factor Trio to control cell shape rearrangement. Further, we provide evidence that RhoB interacted with and positively regulates phosphatase PP2A through the recruitment of its regulatory subunit B55, which was found to be crucial for Akt dephosphorylation. B55 inhibition completely suppressed RhoB-mediated PP2A regulation. Finally, we show that PP2A inactivation, by targeting either its catalytic or its regulatory B55 subunit, completely reversed RhoB-dependent morphological changes and also fully prevented the ability of RhoB to decrease the invasiveness of bronchial cells. Altogether, these results highlight a novel signaling axis and describe new molecular mechanisms that could explain the tumor suppressor role of RhoB in lung cancer. Therefore, we propose that RhoB could be responsible for early metastatic prevention by inhibiting the EMT-derived invasiveness of lung cells through the control of PP2A activity.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/genética , Proteína Fosfatasa 2/genética , Proteína de Unión al GTP rhoB/genética , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Transición Epitelial-Mesenquimal/genética , Regulación Neoplásica de la Expresión Génica , Humanos , Células Madre Mesenquimatosas/metabolismo , Células Madre Mesenquimatosas/patología , Invasividad Neoplásica/genética , Regiones Promotoras Genéticas , Proteína Fosfatasa 2/biosíntesis , Transducción de Señal , Proteína de Unión al GTP rhoB/biosíntesisRESUMEN
INTRODUCTION: Vesicourethral anastomotic stricture following prostatectomy is uncommon but represents a challenge for reconstructive surgery and has a significant impact on quality of life. The aim of this study was to relate our experience in managing vesicourethral anastomotic strictures and present the treatment algorithm used in our institution. PATIENTS AND METHODS: We performed a descriptive, retrospective study in which we assessed the medical records of 45 patients with a diagnosis of vesicourethral anastomotic stricture following radical prostatectomy. The patients were treated in the same healthcare centre between January 2002 and March 2015. Six patients were excluded for meeting the exclusion criteria. The stricture was assessed using cystoscopy and urethrocystography. The patients with patent urethral lumens were initially treated with minimally invasive procedures. Open surgery was indicated for the presence of urethral lumen obliteration or when faced with failure of endoscopic treatment. Urinary continence following the prostatectomy was determinant in selecting the surgical approach (abdominal or perineal). RESULTS: Thirty-nine patients treated for vesicourethral anastomotic stricture were recorded. The mean age was 64.4 years, and the mean follow-up was 40.3 months. Thirty-three patients were initially treated endoscopically. Seventy-five percent progressed free of restenosis following 1 to 4 procedures. Twelve patients underwent open surgery, 6 initially due to obliterative stricture and 6 after endoscopic failure. All patients progressed favourable after a mean follow-up of 29.7 months. CONCLUSIONS: Endoscopic surgery is the initial treatment option for patients with vesicourethral anastomotic strictures with patent urethral lumens. Open reanastomosis is warranted when faced with recalcitrant or initially obliterative strictures and provides good results.
Asunto(s)
Complicaciones Posoperatorias/cirugía , Prostatectomía , Estrechez Uretral/cirugía , Obstrucción del Cuello de la Vejiga Urinaria/cirugía , Anciano , Anastomosis Quirúrgica , Humanos , Masculino , Persona de Mediana Edad , Prostatectomía/métodos , Estudios Retrospectivos , Estrechez Uretral/complicaciones , Obstrucción del Cuello de la Vejiga Urinaria/complicaciones , Procedimientos Quirúrgicos Urológicos/métodosRESUMEN
INTRODUCTION: Only four cases of Hapalopilus rutilans poisoning have been previously published. We report two new cases. CASE REPORTS: A father and his 13-year-old daughter picked mushrooms identified as Fistulina hepatica specimens and ate an unknown quantity (Hour 0). At Hour 12 post-ingestion, both subjects complained of abdominal pain, then nausea, vomiting, anorexia, asthenia, diplopia, and blurred vision. The father also had visual hallucinations. On Day 2 post-ingestion, clinical examination showed multidirectional nystagmus. The father also had balance disorders and both subjects emitted purple urine. Laboratory tests showed elevated serum creatinine and blood urea levels, proteinuria and leukocyturia in both subjects, and mild elevation of hepatic enzymes in the father. Urine color returned to normal on Day 2 and Day 7 post-ingestion in the girl and her father, respectively. Complete clinical and biochemical recovery was obtained within one week in both cases. DISCUSSION: Signs and symptoms are similar to those previously reported after H. rutilans ingestion. This mushroom can be easily confused with F. hepatica. Purple discoloration of the urine after ingestion of a polyporic mushroom is highly suggestive of H. rutilans poisoning. Polyporic acid is probably the active toxin.
Asunto(s)
Dolor Abdominal/etiología , Benzoquinonas/envenenamiento , Intoxicación por Setas/diagnóstico , Intoxicación por Setas/fisiopatología , Orina/química , Adolescente , Adulto , Benzoquinonas/aislamiento & purificación , Color , Femenino , Alucinaciones/etiología , Humanos , Masculino , Nistagmo Patológico/etiologíaRESUMEN
The hippocampal formation is essential for normal memory function and is implicated in many neurodevelopmental, neurodegenerative and neuropsychiatric disorders. In particular, abnormalities in hippocampal structure and function have been identified in schizophrenic subjects. Schizophrenia has a strong polygenic component, but the role of numerous susceptibility genes in normal brain development and function has yet to be investigated. Here we described the expression of schizophrenia susceptibility genes in distinct regions of the monkey hippocampal formation during early postnatal development. We found that, as compared with other genes, schizophrenia susceptibility genes exhibit a differential regulation of expression in the dentate gyrus, CA3 and CA1, over the course of postnatal development. A number of these genes involved in synaptic transmission and dendritic morphology exhibit a developmental decrease of expression in CA3. Abnormal CA3 synaptic organization observed in schizophrenics might be related to some specific symptoms, such as loosening of association. Interestingly, changes in gene expression in CA3 might occur at a time possibly corresponding to the late appearance of the first clinical symptoms. We also found earlier changes in expression of schizophrenia susceptibility genes in CA1, which might be linked to prodromal psychotic symptoms. A number of schizophrenia susceptibility genes including APOE, BDNF, MTHFR and SLC6A4 are involved in other disorders, and thus likely contribute to nonspecific changes in hippocampal structure and function that must be combined with the dysregulation of other genes in order to lead to schizophrenia pathogenesis.
Asunto(s)
Apolipoproteínas E , Factor Neurotrófico Derivado del Encéfalo , Regulación del Desarrollo de la Expresión Génica , Hipocampo , Metilenotetrahidrofolato Reductasa (NADPH2) , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Animales , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Región CA1 Hipocampal/crecimiento & desarrollo , Región CA1 Hipocampal/metabolismo , Región CA3 Hipocampal/crecimiento & desarrollo , Región CA3 Hipocampal/metabolismo , Giro Dentado/crecimiento & desarrollo , Giro Dentado/metabolismo , Perfilación de la Expresión Génica , Hipocampo/crecimiento & desarrollo , Hipocampo/metabolismo , Macaca mulatta , Masculino , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Metilenotetrahidrofolato Reductasa (NADPH2)/metabolismo , Esquizofrenia/genética , Esquizofrenia/metabolismo , Proteínas de Transporte de Serotonina en la Membrana Plasmática/genética , Proteínas de Transporte de Serotonina en la Membrana Plasmática/metabolismo , Factores de TiempoRESUMEN
Of critical importance in the stress response is the post-transcriptional control of the expression of important genes involved in the control of cell survival and apoptosis. Here we report that miR-19, an oncogenic component of the miR-17-92/Oncomir-1 microRNA polycistron, regulates the expression of Ras homolog B (RhoB) in keratinocytes upon exposure to ultraviolet (UV) radiation. Strikingly, we could not find any evidence for deregulated expression of miR-19 during UV treatment. However, we show that miR-19-mediated regulation of antiapoptotic RhoB expression requires the binding of human antigen R (HuR), an AU-rich element binding protein, to the 3'-untranslated region of the rhoB mRNA. We propose that the loss of the interdependent binding between HuR and miR-19 to the rhoB mRNA upon UV exposure relieves this mRNA from miR-19-dependent inhibition of translation and contributes to the apoptotic response.
Asunto(s)
Apoptosis/efectos de la radiación , Proteínas ELAV/metabolismo , MicroARNs/metabolismo , ARN Mensajero/metabolismo , Rayos Ultravioleta , Proteína de Unión al GTP rhoB/metabolismo , Regiones no Traducidas 3' , Sitios de Unión , Línea Celular , Proteínas ELAV/antagonistas & inhibidores , Proteínas ELAV/genética , Humanos , Luciferasas de Luciérnaga/genética , Luciferasas de Luciérnaga/metabolismo , Unión Proteica , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Proteína de Unión al GTP rhoB/genéticaRESUMEN
Late malignancies have been discussed as a potential risk for growth factor mobilized donors of hematopoietic stem cells. Little is known about the incidence and potential risk factors. This single center retrospective cohort study evaluated all HLA-identical sibling pairs with hematopoietic stem cell transplantation (HSCT) for a hematological malignancy, treated from 1974 to 2001 at the University Hospital of Basel. Three hundred eighteen pairs were identified, 291 donors (92%) could be contacted. Median observation time was 13.8 years (range 5-32 years). Sixteen (5%) donors had developed a total of 18 tumors, 17 recipients a secondary tumor. According to the age- and sex-adapted cancer incidence, 3.3 tumors in male and 6.8 in female donors were expected, 3 (relative risk (RR): 0.91, 95% confidence interval: 0.19-2.66) and 4 (RR: 0.58, 95% confidence interval: 0.16-1.48), respectively, were found in donors between 0 and 49 years. Between 50 and 69 years, 4.5 tumors in males and 4.8 in females were expected, 5 (RR: 1.11, 95% confidence interval: 0.36-2.59) and 6 (RR: 1.23, 95% confidence interval: 0.45-2.67), respectively, were observed. Tumors do occur in donors of hematopoietic stem cells at least at the rate as expected in a normal population; whether incidence exceeds expected rates needs to be determined in larger international cohorts.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas/estadística & datos numéricos , Neoplasias/epidemiología , Donantes de Tejidos/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Estudios de Cohortes , Femenino , Alemania/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Suiza/epidemiología , Adulto JovenRESUMEN
The incidence of neoplastic complications after solid organ transplantation is increasing tremendously probably as the consequence of long term immunosuppression. Beside usual risk factors, the oncogenic role of some viruses like Epstein-Barr virus is well established. We report a case of a primitive EBV-induced liver leiomyosarcoma after renal transplantation.